日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

P641 Implementation and short-term adverse events of anti-SARS-CoV-2 vaccines in Inflammatory Bowel Disease patients: an international web-based survey

P641 抗SARS-CoV-2疫苗在炎症性肠病患者中的实施及短期不良事件:一项国际网络调查

Bishu, Shrinivas; Ungaro, R; Siegel, C A; Cree, B A C; Selmaj, K W; Ahmad, H A; Pai, A; Ather, S; Henry, A; Charles, L; Petersen, A; Cheng, C Y; Afsari, S; Sheffield, J; Vaile, J; Colombel, J F; Mayorga Ayala, L F; Herrera-deGuise, C; Esperalba, J; Martinez-Gomez, X; Céspedes Martinez, E; Robles Alonso, V; Jimenez, A; Perez Martinez, Z; Oller, E; Ibarz, A; Fernandez-Naval, C; Martinez-Gallo, M; Lopez Messeguer, M; Casellas, F; Borruel, N; Lelong, M; Nancey, S; Bouguen, G; Allez, M; Serrero, M; Chupin, A; Caillo, L; Viennot, S; Blanc, P; Reimund, J M; Laharie, D; Olivier, R; Laurent, P B; Dib, N; De Maissin, A; Montuclard, C; Trang-Poisson, C; Gaillot, G; Bressollette-Bodin, C; Berthome, M; Burel, M; Vavasseur, F; Bourreille, A; Le Berre, C; Reinisch, W; Colombel, J F; D’Haens, G R; Rimola, J; DeHaas-Amatsaleh, A; McKevitt, M; Ren, X; Serone, A; Schwartz, D A; Gecse, K B; Peyrin-Biroulet, L; Colombel, J F; Louis, E; Ferrante, M; Motoya, S; Panaccione, R; Torres, J; Ungaro, R C; Kligys, K; Kalabic, J; Zambrano, J; Zhang, Y; D’Haens, G R; de Voogd, F; Bots, S; Van Wassenaer, E; De Jong, M; Pruijt, M; Löwenberg, M; D’Haens, G; Gecse, K; Otten, A T; Bourgonje, A R; Horinga, P P; van der Meulen, H H; van Leer-Buter, C C; Dijkstra, G; Visschedijk, M C; Orfanoudaki, E; Zacharopoulou, E; Kitsou, V; Karmiris, K; Theodoropoulou, A; Mantzaris, G J; Tzouvala, M; Michopoulos, S; Zampeli, E; Michalopoulos, G; Karatzas, P; Viazis, N; Liatsos, C; Bamias, G; Koutroubakis, I E; Martin Arranz, M D; García Ramírez, L; Montero Vega, D; Martín-Arraz, E; Sánchez Azofra, M; Poza Cordon, J; Rueda Garcia, J L; Noci Belda, J; Verges Martínez-Meco, T; Blanco San Miguel, P; Suarez Ferrer, C; Babayeva-Sadigova, G; Makhmudov, U; Quliyev, F; Asadova, G; Mirzazade, O; Samadova, T; Hasanova, A; Costantino, A; Caprioli, F; Vecchi, M; Stocco, D; Aloi, M; Armuzzi, A; Ficari, F; Manguso, F; Mocci, G; Orlando, A; Pironi, L; Radice, S; Rizzello, F; Tongiorgi, A; Leone, S; Bossa, F; Saifuddin, A; Kent, A; Mehta, S; Hicks, L; Gonzalez, H; Segal, J; Brooks, M; Subramanian, S; Bhala, N; Conley, T; Patel, K; Lamb, C; Walker, G; Kennedy, N; Sebastian, S; Geldof, J; Sabino, J; Ferrante, M; Lambert, J; Lapeere, H; Hillary, T; Van Laethem, A; De Vlam, K; Verschueren, P; Lobaton, T; Vermeire, S; Bossuyt, P; Bresso, F; Dubinsky, M; Ha, C; Siegel, C; Zambrano, J; Kligys, K; Kalabic, J; Zhang, Y; Panaccione, R; Ramos Lopez, L; Hernández, A; Carrillo-Palau, M; Hernández-Camba, A; Alonso-Abreu, I; Reygosa, C; Vela, M; Rodríguez, G E; González-Mendez, Y; Tardillo, C; Arranz, L; Benítez-Zafra, F; Hernández-Guerra, M; Taxonera Samso, C; Olivares, D; Blanco, I; Velasco, E; Molina, S; López, G; López-García, O N; Alba, C; Rey, E; López Marte, P; Ramos-Tollinchi, L; Rodriguez-Martinó, E; Medina-Prieto, R; Ojeda, S; Santana-Bagur, J; Pantoja, P; Sariol, C A; Torres, E A; Macedo Silva, V; Lima Capela, T; Freitas, M; Cúrdia Gonçalves, T; Boal Carvalho, P; Dias de Castro, F; Moreira, M J; Cotter, J; Revés, J; Abreu, B; Chaparro, M; Gisbert, J P; Mariangela, A; Fiorino, G; Barberio, B; Zingone, F; Pisani, A; Cassar, D; Michalopoulos, G; Mantzaris, G; Mountaki, K; Koutroubakis, I; Karmiris, K; Katsanos, K; Ďuricova, D; Burisch, J; Madsen, G R; Maaser, C; Naila, A; Orfanoudaki, E; Milivojevic, V; Buisson, A; Avedano, L; Leone, S; Torres, J; Ellul, P

OP22 Antibody decay, T cell immunity and breakthrough infections following SARS-CoV-2 vaccination in infliximab- and vedolizumab-treated patients

OP22 抗体衰减、T细胞免疫和SARS-CoV-2疫苗接种后英夫利昔单抗和维多珠单抗治疗患者的突破性感染

Jeong, Geum Hee; Huh, Sun; Lin, S; Kennedy, N A; Saifuddin, A; Muñoz Sandoval, D; Reynolds, C J; Seoane, R C; Kottoor, S H; Pieper, F P; Lin, K M; Butler, D K; Chanchlani, N; Nice, R; Chee, D; Bewshea, C; Janjua, M; McDonald, T J; Sebastian, S; Alexander, J L; Constable, L; Lee, J C; Murray, C D; Hart, A L; Irving, P M; Jones, G R; Kok, K B; Lamb, C A; Lees, C W; Altmann, D M; Boyton, R J; Goodhand, J R; Powell, N; Ahmad, T

OP03 Anti-SARS-CoV2 antibody responses are attenuated in patients with Inflammatory Bowel Disease treated with infliximab

OP03 抗SARS-CoV-2抗体反应在接受英夫利昔单抗治疗的炎症性肠病患者中减弱

Delvaux, M; Kennedy, N A; Goodhand, J; Bewshea, C; Nice, R; Chee, D; Lin, S; Chanchlani, N; Butterworth, J; Cooney, R; Croft, N; Hart, A; Irving, P; Kok, K; Lamb, C; Limdi, J; MacDonald, J; McGovern, D; Mehta, S; Murray, C; Patel, K; Pollok, R; Raine, T; Russell, R; Selinger, C; Smith, P; Bowden, J; McDonald, T; Lees, C; Sebastian, S; Powell, N; Ahmad, T

DOP35 Ambulatory care management of 70 patients with Acute Severe Ulcerative Colitis in comparison to 700 inpatients: Insights from a multicentre UK cohort study

DOP35 一项英国多中心队列研究比较了70例急性重症溃疡性结肠炎患者的门诊治疗与700例住院治疗:

Vege, Santhi Swaroop; Yadav, Dhiraj; Chari, Suresh; Patel, K V; Segal, J; Sebastian, S; Subramanian, S; Conley, T; Gonzalez, H; Kent, A; Saifuddin, A; Hicks, L; Mehta, S; Bhala, N; Brookes, M; Lamb, C; Kennedy, N; Walker, G

P275 Course of COVID-19 in patients with Inflammatory Bowel Diseases treated with biologics: the Israeli experience

P275 接受生物制剂治疗的炎症性肠病患者的 COVID-19 病程:以色列的经验

Garrido, Isabel; Lopes, Susana; Macedo, Guilherme; Kennedy, N A; Goodhand, J; Bewshea, C; Nice, R; Chee, D; Lin, S; Chanchlani, N; Butterworth, J; Cooney, R; Croft, N; Hart, A; Irving, P; Kok, K; Lamb, C; Limdi, J; MacDonald, J; McGovern, D; Mehta, S; Murray, C; Patel, K; Pollok, R; Raine, T; Russell, R; Selinger, C; Smith, P; Bowden, J; McDonald, T; Lees, C; Sebastian, S; Powell, N; Ahmad, T; Chaparro, M; Garre, A; Iborra, M; Sierra, M; Barreiro-de Acosta, M; Fernández-Clotet, A; de Castro, L; Boscá-Watts, M; Casanova, M J; López-García, A; Lorente, R; Rodríguez, C; Carbajo, A Y; Arroyo, M T; Gutiérrez, A; Hinojosa, J; Martínez-Pérez, T; Villoria, A; Bermejo, F; Busquets, D; Camps, B; Cañete, F; Manceñido, N; Monfort, D; Navarro-Llavat, M; Pérez-Calle, J L; Ramos, L; Rivero, M; Angueira, T; Camo, P; Carpio, D; García-de-la-Filia, I; González-Muñoza, C; Hernández, L; Huguet, J M; Morales, V J; Sicilia, B; Vega, P; Domènech, E; Gisbert, J P; Lamb, C A; Sebastian, S; Kent, A J; Segal, J P; Gonzalez, H A; Brookes, M J; Mehta, S J; Subramanian, S; Bhala, N; Hicks, L C; Conley, T E; Patel, K V; Walker, G J; Kennedy, N A; Lichtenstein, L; Koslowsky, B; Avni-Biron, I; Ovadia, B; Ben-Bassat, O; Naftali, T; Kopylov, U; Haberman, Y; Banai Eran, H; Eliakim, R; Lahat-Zok, A; Hirsch, A; Zittan, E; Maharshak, N; Waterman, M; Israeli, E; Goren, I; Ollech, J E; Yanai, H; Ungar, B; Avidan, B; Ben Hur, D; Melamud, B; Segol, O; Shalem, Z; Dotan, I; Odes, S H; Ben-Horin, S; Snir, Y; Milgrom, Y; Broide, E; Goldin, E; Delgado, S; Ron, Y; Cohen, N A; Maoz, E; Zborovski, M; Odeh, S; Abu Freha, N; Bar-Gil Shitrit, A

OP24 Efficacy and safety of upadacitinib induction therapy in patients with Moderately to Severely Active Ulcerative Colitis: Results from the phase 3 U-ACHIEVE study

OP24 乌帕替尼诱导治疗中重度活动性溃疡性结肠炎患者的疗效和安全性:来自 3 期 U-ACHIEVE 研究的结果

Papamichael, Konstantinos; Cheifetz, Adam S; Martin Arranz, E; Suarez Ferrer, C; García Ramirez, L; Sanchez Azofra, M; Rueda García, J L; Poza Cordón, J; Martín Arranz, M D; García Mateo, S; Refaie, E; Martínez-Domínguez, S J; Gargallo-Puyuelo, C J; Lario Quilez, L; Carrera-Lasfuentes, P; Arroyo Villarino, M T; Aso Gonzalvo, M C; Gomollón García, F; Attauabi, M; Poulsen, A; Kajbæk Verner-Andersen, M; Rosager Hansen, M; Pedersen, N; Pilegaard Prahm, A; Berg Lødrup, A; Haderselv, K; Larsen, L; Jess, T; Glerup, H; Molazahi, A; Mathiassen Oppfeldt, A; Dahlerup, J F; Lodberg Hvas, C; Neumann, A; Wase, A; Dam Jensen, M; Nathan, T; Jensen, S; Theede, K; Kiszka-Kanowitz, M; Benedict Seidelin, J; Burisch, J; Calafat Sard, M; González-Muñoza, C; Fortuny, M; Roig, C; Calm, A; Mombiela, A; Teller-Martin, M; Cañete, F; Bertoletti, F; González-González, L; Gordillo, J; Mañosa, M; Garcia-Planella, E; Domènech, E; Geldof, J; Truyens, M; Sabino, J; Ferrante, M; Lambert, J; Lapeere, H; Hillary, T; Van Laethem, A; De Vlam, K; Verschueren, P; Lobaton, T; Vermeire, S; Patel, K V; Segal, J; Sebastian, S; Subramanian, S; Conley, T; Gonzalez, H; Kent, A; Saifuddin, A; Hicks, L; Mehta, S; Bhala, N; Brookes, M; Lamb, C; Kennedy, N; Walker, G; Ungaro, R; Chou, B; Mo, J; Ursos, L; Twardowski, R; Candela, N; Colombel, J F; Calviño Suárez, C; Dos-Santos, R; Baston-Rey, I; Montero, F J; Ferreiro-Iglesias, R; Marin-Jimenez, I; Gonzalez, C M; Perez-Pampin, E; Barreiro-de Acosta, M; Ricciuto, A; Lamb, C; Benchimol, E I; Walker, G; Kennedy, N; Kuenzig, M E; Kaplan, G; Griffiths, A M; Reinisch, W; Sebastian, S; García Mateo, S; Martínez-Domínguez, S J; Aso Gonzalvo, M C; Gargallo-Puyuelo, C J; Gallego Llera, B; Arroyo Villarino, M T; Laredo de la Torre, V; Nocito Colon, M M L; Lario Quilez, L; Refaie, E; Latre Santos, M; Gomollón García, F; Hernandez Camba, A; Ramos, L; Madrid Álvarez, M B; Pérez-Méndez, L; Nos, P; Hernández, V; Guerra, I; Jimenez, N; Lorente, R; Sierra-Ausín, M; Ginard, D; Varela, P; Arranz, L; Cabello Tapia, M J; Zabana, Y; Barreiro, M; Koletzko, L; Klucker, E; Le Thi, G; Breiteneicher, S; Rubio-Acero, R; Neuhaus, L; Stark, R; Standl, M; Hölscher, M; Török, H; Koletzko, S; Schwerd, T; Fiske, J; Liu, E; Limdi, J; Conley, T E; Townsend, T; Davies, M; Brockwell, R; Baig, D; Abdelbadiee, S; Uney, A; Liaros, A; Gaba, W; Smith, P J; Subramanian, S; Lamers, C R; de Roos, N M; Heerink, H H; van de Worp - Kalter, L A; Witteman, B J M; Lo, B Z S; Mokrowiecka, A; Mikocka-Walus, A; Bernstein, C N; Trindade, I A; Burisch, J; Barreiro-de Acosta, M; Ferreira, N; Gearry, R B; Knowles, S R; Scheffers, L; van den Berg, L E; Pijnenburg, M W; Utens, E M; Dieleman, G C; van der Ploeg, A T; Helbing, W A; Escher, J C; Danese, S; Vermeire, S; Zhou, W; Pangan, A; Siffledeen, J; Hébuterne, X; Nakase, H; Higgins, P; Chen, M H; Sanchez-Gonzalez, Y; Huang, B; Xie, W; Liu, J; Weinreich, M; Pannaccione, R

P401 Risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications: Reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study

P401 炎症性肠病药物与严重 COVID-19 后果风险相关:来自英国 PREPARE-IBD 多中心队列研究的令人安心的见解

Navaneethan, Udayakumar; Konjeti, Rajesh; Venkatesh, Preethi Gk; Sanaka, Madhusudhan R; Parsi, Mansour A; Lamb, C A; Sebastian, S; Kent, A J; Segal, J P; Gonzalez, H A; Brookes, M J; Mehta, S J; Subramanian, S; Bhala, N; Hicks, L C; Conley, T E; Patel, K V; Walker, G J; Kennedy, N A

P401 Risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications: Reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study

P401 炎症性肠病药物与严重 COVID-19 后果风险相关:来自英国 PREPARE-IBD 多中心队列研究的令人安心的见解

Anderson, Carolyn J; Bulte, Jeff W M; Chen, Kai; Chen, Xiaoyuan; Khaw, Ban-An; Shokeen, Monica; Wooley, Karen L; VanBrocklin, Henry F; Lamb, C A; Sebastian, S; Kent, A J; Segal, J P; Gonzalez, H A; Brookes, M J; Mehta, S J; Subramanian, S; Bhala, N; Hicks, L C; Conley, T E; Patel, K V; Walker, G J; Kennedy, N A

A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis.

RNF186 中的蛋白质截短变体 R179X 可预防溃疡性结肠炎

Rivas Manuel A, Graham Daniel, Sulem Patrick, Stevens Christine, Desch A Nicole, Goyette Philippe, Gudbjartsson Daniel, Jonsdottir Ingileif, Thorsteinsdottir Unnur, Degenhardt Frauke, Mucha Sören, Kurki Mitja I, Li Dalin, D'Amato Mauro, Annese Vito, Vermeire Severine, Weersma Rinse K, Halfvarson Jonas, Paavola-Sakki Paulina, Lappalainen Maarit, Lek Monkol, Cummings Beryl, Tukiainen Taru, Haritunians Talin, Halme Leena, Koskinen Lotta L E, Ananthakrishnan Ashwin N, Luo Yang, Heap Graham A, Visschedijk Marijn C, MacArthur Daniel G, Neale Benjamin M, Ahmad Tariq, Anderson Carl A, Brant Steven R, Duerr Richard H, Silverberg Mark S, Cho Judy H, Palotie Aarno, Saavalainen Päivi, Kontula Kimmo, Färkkilä Martti, McGovern Dermot P B, Franke Andre, Stefansson Kari, Rioux John D, Xavier Ramnik J, Daly Mark J, Barrett J, de Lane K, Edwards C, Hart A, Hawkey C, Jostins L, Kennedy N, Lamb C, Lee J, Lees C, Mansfield J, Mathew C, Mowatt C, Newman B, Nimmo E, Parkes M, Pollard M, Prescott N, Randall J, Rice D, Satsangi J, Simmons A, Tremelling M, Uhlig H, Wilson D, Abraham C, Achkar J P, Bitton A, Boucher G, Croitoru K, Fleshner P, Glas J, Kugathasan S, Limbergen J V, Milgrom R, Proctor D, Regueiro M, Schumm P L, Sharma Y, Stempak J M, Targan S R, Wang M H

Implementation of a 'care bundle' improves the management of patients admitted to hospital with decompensated cirrhosis

实施“综合护理方案”可改善失代偿期肝硬化住院患者的管理。

Dyson, J K; Rajasekhar, P; Wetten, A; Ashraf, H H; Ng, S; Paremal, S; Baqai, M F; Lamb, C A; Masson, S; Hudson, M; Dipper, C; Cowlam, S; Hussaini, H; McPherson, S